Press
Flipping the switch: Salk scientists shed new light on genetic changes that turn “on” cancer genes
LA JOLLA—Cancer, caused by abnormal overgrowth of cells, is the second-leading cause of death in the world. Researchers from the Salk Institute have zeroed in on specific mechanisms that activate oncogenes, which are altered genes that can cause normal cells to become cancer cells.
Salk appoints Jesse Dixon as assistant professor
LA JOLLA—The Salk Institute has appointed molecular biologist Jesse Dixon to the rank of assistant professor for his significant work in uncovering how the human genome, the DNA blueprint for life, is organized in three-dimensional space inside of cells. The appointment was based on recommendations by Salk faculty, and approved by Salk President Rusty Gage and the Institute’s Board of Trustees.
Salk scientists develop technique to reveal epigenetic features of cells in the brain
LA JOLLA—The brain’s prefrontal cortex, which gives us our ability to solve problems and plan ahead, contains billions of cells. But understanding the large diversity of cell types in this critical region, each with unique genetic and molecular properties, has been challenging.
Salk Fellow Jesse Dixon receives NIH Director’s Early Independence Award
LA JOLLA—Helmsley-Salk Fellow Jesse Dixon is among 16 scientists nationwide to receive the Director’s Early Independence Award from the National Institutes of Health (NIH) to pursue promising and innovative research. Dixon is the third Salk Fellow to receive the prestigious award since it was established in 2010.